Trial Profile
Phase II trial of depsipeptide (NSC-630176) [romidepsin] in colorectal cancer patients who have received either one or two prior chemotherapy regimens for metastatic or locally advanced, unresectable disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Apr 2023
Price :
$35
*
At a glance
- Drugs Romidepsin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 23 Aug 2005 New trial record.